Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 6/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.60 |
| ▸ | TSHR | P16473 | 5/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29736830 | 0.75 | CYP2A6 (1.00) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL28814927 | 0.75 | CYP2A6 (1.00) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL29352216 | 0.75 | TSHR (0.65) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL49861 | 0.75 | CYP2A6 (1.00) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL2951616 | 0.75 | TSHR (0.65) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL19505243 | 0.73 | CYP1A2 (0.40) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL2810486 | 0.73 | CYP2A6 (0.95) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL9614419 | 0.73 | CYP2A6 (0.95) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| SCHEMBL2810487 | 0.73 | CYP2A6 (0.95) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 | |
| Lithium SCHEMBL30066819 | 0.73 | TSHR (0.62) | CYP2A6CYP1A2TSHRALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108352456-B | Organic electroluminescent device | 诺瓦尔德股份有限公司 | 2020-03-20 | — | — | CN | disclosed |
| EP-2217607-B1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | CANON KK (JP) | 2016-11-02 | — | — | EP | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-20110301310-A1 | Pyridyldiamido Transition Metal Complexes, Production And Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-12-08 | — | — | US | disclosed |
| WO-2011153377-A2 | METHODS AND COMPOSITIONS FOR TREATING A SUBJECT FOR CENTRAL NERVOUS SYSTEM (CNS) INJURY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-12-08 | — | — | WO | disclosed |
| WO-2010110554-A2 | ORGANIC ELECTROLUMINESCENT DEVICE USING ORGANIC ELECTROLUMINESCENT COMPOUNDS | DOW ADVANCED DISPLAY MATERIALS,LTD. (KR) | 2010-09-30 | — | — | WO | disclosed |
| WO-2000039088-A1 | GLUCAGON ANTAGONISTS/INVERSE AGONISTS | NOVO NORDISK A/S (DK) | 2000-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301310-A1 | Pyridyldiamido Transition Metal Complexes, Production And Use Thereof | PNPO, PLPBP, PDXK | CYP2A6 1415/4885CYP1A2 724/4885TSHR 4158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.